These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
518 related items for PubMed ID: 27896433
21. Physical activity correlates with neurological impairment and disability in multiple sclerosis. Motl RW, Snook EM, Wynn DR, Vollmer T. J Nerv Ment Dis; 2008 Jun; 196(6):492-5. PubMed ID: 18552627 [Abstract] [Full Text] [Related]
22. Walking capacities in multiple sclerosis measured by global positioning system odometer. Créange A, Serre I, Levasseur M, Audry D, Nineb A, Boërio D, Moreau T, Maison P, Réseau SINDEFI-SEP. Mult Scler; 2007 Mar; 13(2):220-3. PubMed ID: 17439888 [Abstract] [Full Text] [Related]
23. Physical Activity Monitoring Using a Fitbit Device in Ischemic Stroke Patients: Prospective Cohort Feasibility Study. Katzan I, Schuster A, Kinzy T. JMIR Mhealth Uhealth; 2021 Jan 19; 9(1):e14494. PubMed ID: 33464213 [Abstract] [Full Text] [Related]
24. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL. Radiology; 2000 Mar 19; 214(3):665-70. PubMed ID: 10715027 [Abstract] [Full Text] [Related]
25. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis. D'hooghe MB, Haentjens P, Nagels G, Garmyn M, De Keyser J. Mult Scler; 2012 Apr 19; 18(4):451-9. PubMed ID: 21952096 [Abstract] [Full Text] [Related]
26. Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis. Block VJ, Cheng S, Juwono J, Cuneo R, Kirkish G, Alexander AM, Khan M, Akula A, Caverzasi E, Papinutto N, Stern WA, Pletcher MJ, Marcus GM, Olgin JE, Hauser SL, Gelfand JM, Bove R, Cree BA, Henry RG. Mult Scler; 2023 Mar 19; 29(3):363-373. PubMed ID: 36573559 [Abstract] [Full Text] [Related]
27. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis. Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S. Neurorehabil Neural Repair; 2011 Sep 19; 25(7):672-9. PubMed ID: 21436388 [Abstract] [Full Text] [Related]
28. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure. Pau M, Caggiari S, Mura A, Corona F, Leban B, Coghe G, Lorefice L, Marrosu MG, Cocco E. Mult Scler Relat Disord; 2016 Nov 19; 10():187-191. PubMed ID: 27919488 [Abstract] [Full Text] [Related]
29. Accuracy of step count measured by physical activity monitors: The effect of gait speed and anatomical placement site. Chow JJ, Thom JM, Wewege MA, Ward RE, Parmenter BJ. Gait Posture; 2017 Sep 19; 57():199-203. PubMed ID: 28666177 [Abstract] [Full Text] [Related]
30. Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis. Achiron A, Barak Y, Rotstein Z. Mult Scler; 2003 Oct 19; 9(5):486-91. PubMed ID: 14582775 [Abstract] [Full Text] [Related]
31. Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosis. Block VJ, Zhao C, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Henry R, Gelfand JM, Cree BA. Mult Scler J Exp Transl Clin; 2019 Oct 19; 5(4):2055217319888660. PubMed ID: 31803492 [Abstract] [Full Text] [Related]
32. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. Vukusic S, Confavreux C. J Neurol Sci; 2003 Feb 15; 206(2):135-7. PubMed ID: 12559500 [Abstract] [Full Text] [Related]
33. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M. Arch Neurol; 2007 Aug 15; 64(8):1163-8. PubMed ID: 17698707 [Abstract] [Full Text] [Related]
34. Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS. Bosma L, Kragt JJ, Polman CH, Uitdehaag BM. Mult Scler; 2013 Mar 15; 19(3):326-33. PubMed ID: 22907939 [Abstract] [Full Text] [Related]
35. Progressive multiple sclerosis patients have a higher burden of autonomic dysfunction compared to relapsing remitting phenotype. Adamec I, Crnošija L, Junaković A, Krbot Skorić M, Habek M. Clin Neurophysiol; 2018 Aug 15; 129(8):1588-1594. PubMed ID: 29885648 [Abstract] [Full Text] [Related]
37. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS. Neurology; 2007 Oct 09; 69(15):1498-507. PubMed ID: 17699802 [Abstract] [Full Text] [Related]
38. Validation of Fitbit-Flex as a measure of free-living physical activity in a community-based phase III cardiac rehabilitation population. Alharbi M, Bauman A, Neubeck L, Gallagher R. Eur J Prev Cardiol; 2016 Sep 09; 23(14):1476-85. PubMed ID: 26907794 [Abstract] [Full Text] [Related]
39. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Hohol MJ, Orav EJ, Weiner HL. Mult Scler; 1999 Oct 09; 5(5):349-54. PubMed ID: 10516779 [Abstract] [Full Text] [Related]
40. Accelerometer cut-points derived during over-ground walking in persons with mild, moderate, and severe multiple sclerosis. Sandroff BM, Riskin BJ, Agiovlasitis S, Motl RW. J Neurol Sci; 2014 May 15; 340(1-2):50-7. PubMed ID: 24635890 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]